5-(4-Chloro-phenyl)-[1,3,4]oxadiazole-2-thiol, 95.0%, 250mg

Flacon à col étroit carré, 125 ml, 38-430, 6 pièce(s)

(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)boronic acid, 98+%, 100mg

3-((2-fluorophenyl)sulfonamido)propanoic acid, 95.0%, 250mg

(1,4,5,6-tetrahydrocyclopenta[c]pyrazol-3-ylmethyl)amine dihydrochloride, 95.0%, 1g

4-Chloro-N-methoxy-N-methylbenzamide, 95.0%, 100g

3-Pyrazol-1-yl-propionitrile, 95%, 250mg

(E)-2-(1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)acetonitrile, 97%, 25g

1,3-Benzoxazol-6-ol, 98%, 2.5g

ETHYL 2-(BOC-AMINO)-5-FLUORO-2,3-DIHYDRO-1H-INDENE-2-CARBOXYLATE, 95.0%, 250mg

Quincorine>98.0%(GC)1g

(R)-tert-Butyl (2-oxopyrrolidin-3-yl)carbamate, 95.0%, 5g

2-Amino-4-hydroxy-6-phenylpyrimidine, 95.0%, 25g